Cerebain Biotech Announces Next Major Step in Its Fight against Alzheimers

Tue, 11/12/2013 - 9:00am
Business Wire

Cerebain Biotech Corp., a subsidiary of Discount Dental Materials, Inc., announced that medical device product development company, Sonos Models, Inc., is set to procure pig omentum for the purpose of testing the first Prototypes of our medical device product for treatment of Alzheimer’s.

Cerebain’s President, Eric Clemons, stated “We are enthusiastic with the pending acquisition of this animal omentum. We have decided to utilize the pig’s omentum in these tests because they are functionally analogous to humans. Our device is being developed to provide recurring omentum stimulation, a novel approach to the treatment for patients suffering from Alzheimer’s disease. We expect these tests to begin between December of this year and January of next year.” About Discount Dental Materials, Inc.

Discount Dental Materials, Inc. was incorporated in Nevada on December 17, 2007. The Company’s business will revolve around the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum. The Company’s approach will consider both a medical device solution as well as a synthetic drug solution. The Company’s operations will be conducted through its wholly-owned subsidiary, Cerebain Biotech Corp.

For more information about Discount Dental and Cerebain Biotech, please visit the Company’s website at and, under the ticker symbol “DDOO”, to view the Company’s public filings and stock quote.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.